ATE343390T1 - Kalzilytische verbindungen - Google Patents
Kalzilytische verbindungenInfo
- Publication number
- ATE343390T1 ATE343390T1 AT01988571T AT01988571T ATE343390T1 AT E343390 T1 ATE343390 T1 AT E343390T1 AT 01988571 T AT01988571 T AT 01988571T AT 01988571 T AT01988571 T AT 01988571T AT E343390 T1 ATE343390 T1 AT E343390T1
- Authority
- AT
- Austria
- Prior art keywords
- calcilytic compounds
- compounds
- calcilytic
- methods
- novel calcilytic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms
- C07F9/655345—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a five-membered ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/54—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24300700P | 2000-10-25 | 2000-10-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE343390T1 true ATE343390T1 (de) | 2006-11-15 |
Family
ID=22916980
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01988571T ATE343390T1 (de) | 2000-10-25 | 2001-10-25 | Kalzilytische verbindungen |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20040014723A1 (de) |
| EP (1) | EP1383511B1 (de) |
| JP (1) | JP2004514659A (de) |
| AT (1) | ATE343390T1 (de) |
| AU (1) | AU2002230579A1 (de) |
| DE (1) | DE60124148T2 (de) |
| ES (1) | ES2273909T3 (de) |
| WO (1) | WO2002034204A2 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY143244A (en) | 2002-11-26 | 2011-04-15 | Smithkline Beecham Corp | Calcilytic compounds |
| PE20050460A1 (es) | 2003-04-23 | 2005-07-08 | Japan Tobacco Inc | COMPUESTOS HETEROCICLICOS COMO ANTAGONISTAS CaSR (RECEPTOR SENSIBLE AL CALCIO) |
| EP1630157A4 (de) | 2003-05-28 | 2007-05-23 | Japan Tobacco Inc | Casr-antagonist |
| US8039514B2 (en) | 2008-06-05 | 2011-10-18 | Asahi Kasei Pharma Corporation | Sulfonamide compounds and use thereof |
| WO2010113860A1 (ja) * | 2009-03-31 | 2010-10-07 | 第一三共株式会社 | ビフェニル－環状アミン化合物 |
| DE102011083595A1 (de) | 2011-09-28 | 2013-03-28 | Bayer Pharma AG | Inhibition der Wirkung von Interleukin 1 beta zur Behandlung der Endometriose |
| GB201217330D0 (en) | 2012-09-28 | 2012-11-14 | Univ Cardiff | Therapeutic for treating inflammatory lung disorders |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5789397A (en) * | 1991-01-08 | 1998-08-04 | Bone Care International, Inc. | Methods for preparation and use of 1A,24(S)-dihydroxy vitamin D2 |
| DE4141928A1 (de) * | 1991-12-19 | 1993-06-24 | Boehringer Mannheim Gmbh | Neue phosphonobernsteinsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel |
| DE69733649T2 (de) * | 1996-04-09 | 2006-05-18 | NPS Pharmaceuticals, Inc., Salt Lake City | Calcylitische verbindungen |
| UY24949A1 (es) * | 1997-04-08 | 2001-04-30 | Smithkline Beecham Corp | Compuestos calcilíticos |
| AR014975A1 (es) * | 1998-04-08 | 2001-04-11 | Nps Pharma Inc | Compuestos calciliticos, una composicion farmaceutica que los comprende, y el uso de los mismos para la fabricacion de un medicamento |
| MY121054A (en) * | 1998-04-08 | 2005-12-30 | Smithkline Beecham Corp | Calcilytic compounds as calcium receptor antagonists. |
| PE20001456A1 (es) * | 1999-02-02 | 2001-01-28 | Smithkline Beecham Corp | Compuestos calcioliticos |
| AR030684A1 (es) * | 2000-01-24 | 2003-09-03 | Smithkline Beecham Corp | Compuestos calciliticos, uso de dichos compuestos en la manufactura de medicamentos, e intermediarios utiles en la preparacion de dichos compuestos |
-
2001
- 2001-10-25 EP EP01988571A patent/EP1383511B1/de not_active Expired - Lifetime
- 2001-10-25 DE DE60124148T patent/DE60124148T2/de not_active Expired - Lifetime
- 2001-10-25 JP JP2002537258A patent/JP2004514659A/ja not_active Withdrawn
- 2001-10-25 US US10/415,118 patent/US20040014723A1/en not_active Abandoned
- 2001-10-25 AU AU2002230579A patent/AU2002230579A1/en not_active Abandoned
- 2001-10-25 WO PCT/US2001/046233 patent/WO2002034204A2/en active IP Right Grant
- 2001-10-25 ES ES01988571T patent/ES2273909T3/es not_active Expired - Lifetime
- 2001-10-25 AT AT01988571T patent/ATE343390T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| US20040014723A1 (en) | 2004-01-22 |
| WO2002034204A2 (en) | 2002-05-02 |
| WO2002034204A3 (en) | 2003-11-06 |
| AU2002230579A1 (en) | 2002-05-06 |
| EP1383511B1 (de) | 2006-10-25 |
| ES2273909T3 (es) | 2007-05-16 |
| EP1383511A4 (de) | 2005-05-18 |
| JP2004514659A (ja) | 2004-05-20 |
| WO2002034204A8 (en) | 2003-12-24 |
| EP1383511A2 (de) | 2004-01-28 |
| DE60124148D1 (de) | 2006-12-07 |
| DE60124148T2 (de) | 2007-09-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60010098D1 (de) | 28-epirapaloge | |
| TR200202194T2 (tr) | Poliglütamik asit-kamptotesin birleşikleri ve hazırlama yöntemleri | |
| DK1299348T3 (da) | Forbindelser og sammensætninger til levering af aktive midler | |
| DOP2001000151A (es) | Derivados de imidazopirimidina y derivados de triazolopimidina. | |
| ATE289640T1 (de) | Amidofunktionelle aminopolydiorganosiloxane | |
| ATE461217T1 (de) | Glp-1-verbindungen | |
| ATE376996T1 (de) | Antibakterielle mittel | |
| EA199900373A2 (ru) | Фармацевтические композиции | |
| NO20031860D0 (no) | Kahalaolid F | |
| BR0007922A (pt) | Compostos calcilìticos | |
| DE60121587D1 (de) | Zyklische gmp-spezifische phosphodiesteraseinhibitoren | |
| DE60124148D1 (de) | Kalzilytische verbindungen | |
| DK1377574T3 (da) | 6-phenylbenzonaphtyridiner | |
| TR200402030T4 (tr) | İkame edilen I-aminobutan-3-ol-türevleri | |
| AP2002002547A0 (en) | Calcilytic compounds. | |
| BR0112600A (pt) | Compostos calcilìticos | |
| MXPA02011558A (es) | Inhibidores de mmp-2/mp-9 novedosos. | |
| TR199701298T1 (xx) | Tetralinler. | |
| TW200510276A (en) | Calcilytic compounds | |
| NO20024679D0 (no) | Krystallinsk farmasöytikum | |
| CY1110139T1 (el) | Γλυκοπεπτιδικα αντιβιοτικα | |
| DE60232650D1 (de) | Peptiddeformylaseinhibitoren | |
| UA50030A (uk) | Комплексне добриво | |
| ECSP003331A (es) | Compuestos calciliticos | |
| DE60102704D1 (de) | Trioxepan verbindungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |